Literature DB >> 33460260

Unsupervised hierarchical clustering identifies a metabolically challenged subgroup of hypertensive individuals.

Felix C Vaura1, Veikko V Salomaa2, Ilkka M Kantola3, Risto Kaaja1,3, Leo Lahti4, Teemu J Niiranen1,2,3.   

Abstract

The current classification of hypertension does not reflect the heterogeneity in characteristics or cardiovascular outcomes of hypertensive individuals. Our objective was to identify distinct phenotypes of hypertensive individuals with potentially different cardiovascular risk profiles using data-driven cluster analysis. We performed clustering, a procedure that identifies groups with similar characteristics, in 3726 individuals (mean age 59.4 years, 49% women) with grade 2 hypertension (blood pressure ≥160/100 mmHg or antihypertensive medication) selected from FINRISK 1997, 2002, and 2007 cohorts. We computed clusters based on eight factors associated with hypertension: mean arterial pressure, pulse pressure, non-high-density lipoprotein cholesterol, blood glucose, BMI, C-reactive protein, estimated glomerular filtration rate, and alcohol. After that, we used Cox regression models adjusted for age and sex to assess the relative risk of cardiovascular disease (CVD) outcomes between the clusters and a reference group of 11 020 individuals. We observed two comparable clusters in both men and women. The Metabolically Challenged (MC) cluster was characterized by high blood glucose (Z-score 4.4 ± 1.1 vs 0.2 ± 0.8, men; 3.5 ± 1.1 vs 0.0 ± 0.6, women) and elevated BMI (30.4 ± 4.1 vs 28.9 ± 4.3, men; 32.7 ± 4.9 vs 29.3 ± 5.5, women). Over a 10-year follow-up (1034 CVD events), MC had 1.6-fold (95% CI 1.1-2.4) CVD risk compared to non-MC and 2.5-fold (95% CI 1.7-3.7) CVD risk compared to the reference group (P ≤ .009 for both). Using unsupervised hierarchical clustering, we found two phenotypically distinct hypertension subgroups with different risks of CVD complications. This substratification could be used to design studies that explore the differential effects of antihypertensive therapies among subgroups of hypertensive individuals.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  blood pressure; cardiovascular diseases; cluster analysis; epidemiology; hypertension

Mesh:

Substances:

Year:  2020        PMID: 33460260      PMCID: PMC8029868          DOI: 10.1111/jch.13984

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Cohort Profile: The National FINRISK Study.

Authors:  Katja Borodulin; Hanna Tolonen; Pekka Jousilahti; Antti Jula; Anne Juolevi; Seppo Koskinen; Kari Kuulasmaa; Tiina Laatikainen; Satu Männistö; Markku Peltonen; Markus Perola; Pekka Puska; Veikko Salomaa; Jouko Sundvall; Suvi M Virtanen; Erkki Vartiainen
Journal:  Int J Epidemiol       Date:  2018-06-01       Impact factor: 7.196

3.  Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S.

Authors:  Earl S Ford
Journal:  Diabetes Care       Date:  2005-11       Impact factor: 19.112

4.  Prevalence, Correlates, and Prognosis of Healthy Vascular Aging in a Western Community-Dwelling Cohort: The Framingham Heart Study.

Authors:  Teemu J Niiranen; Asya Lyass; Martin G Larson; Naomi M Hamburg; Emelia J Benjamin; Gary F Mitchell; Ramachandran S Vasan
Journal:  Hypertension       Date:  2017-05-30       Impact factor: 10.190

5.  Validation of a new formula for mean arterial pressure calculation: the new formula is superior to the standard formula.

Authors:  Mansour Razminia; Atul Trivedi; Janos Molnar; Monther Elbzour; Mayra Guerrero; Yasser Salem; Aziz Ahmed; Sandeep Khosla; David L Lubell
Journal:  Catheter Cardiovasc Interv       Date:  2004-12       Impact factor: 2.692

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  A new equation to estimate glomerular filtration rate.

Authors:  Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh
Journal:  Ann Intern Med       Date:  2009-05-05       Impact factor: 25.391

8.  Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

9.  Unsupervised hierarchical clustering identifies a metabolically challenged subgroup of hypertensive individuals.

Authors:  Felix C Vaura; Veikko V Salomaa; Ilkka M Kantola; Risto Kaaja; Leo Lahti; Teemu J Niiranen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-16       Impact factor: 3.738

Review 10.  Timeline of History of Hypertension Treatment.

Authors:  Mohammad G Saklayen; Neeraj V Deshpande
Journal:  Front Cardiovasc Med       Date:  2016-02-23
View more
  2 in total

1.  Multi-Trait Genetic Analysis Reveals Clinically Interpretable Hypertension Subtypes.

Authors:  Felix Vaura; Hyunkyung Kim; Miriam S Udler; Veikko Salomaa; Leo Lahti; Teemu Niiranen
Journal:  Circ Genom Precis Med       Date:  2022-05-23

2.  Unsupervised hierarchical clustering identifies a metabolically challenged subgroup of hypertensive individuals.

Authors:  Felix C Vaura; Veikko V Salomaa; Ilkka M Kantola; Risto Kaaja; Leo Lahti; Teemu J Niiranen
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-16       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.